[1]张雪梅,马琪,罗晶晶,等.香茅草黄酮提取物对L-NNA诱导的高血压大鼠降压作用及其机制的研究[J].西部中医药,2020,33(08):12-15.[doi:10.12174/j.issn.1004-6852.2020.08.04]
　ZHANG Xuemei,MA Qi,LUO Jingjing,et al.The Effects of Flavonoid Extract from Xiangmaocao on Lowering Blood Pressure of L-NNA-induced Hypertension Rat Model and the Study on Its Mechanism[J].Western Journal of Traditional Chinese Medicine,2020,33(08):12-15.[doi:10.12174/j.issn.1004-6852.2020.08.04]
点击复制

香茅草黄酮提取物对L-NNA诱导的高血压大鼠降压作用及其机制的研究
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
33
期数:
2020年08期
页码:
12-15
栏目:
出版日期:
2020-08-15

文章信息/Info

Title:
The Effects of Flavonoid Extract from Xiangmaocao on Lowering Blood Pressure of L-NNA-induced Hypertension Rat Model and the Study on Its Mechanism
文章编号:
1004-6852(2020)08-0012-04
作者:
张雪梅1，2，马琪1，罗晶晶1，于杰2，孙湛1△
1 新疆医科大学基础医学院，新疆 乌鲁木齐 830054； 2 昌吉职业技术学院
Author(s):
ZHANG Xuemei1,2, MA Qi1, LUO Jingjing1, YU Jie2, SUN Zhan1△
1 School of Basic Medical Science, Xinjiang Medical University, Urumqi 830054, China;2 Changji Vocational and Technical College
关键词:
香茅草黄酮提取物; 高血压; 降压; 氧化应激; 一氧化氮; 内皮素
Keywords:
flavonoid extract from Xiangmaocao;  hypertension;  lowering blood pressure;  oxidative stress;  NO;  ET-1
分类号:
R544.1
DOI:
10.12174/j.issn.1004-6852.2020.08.04
文献标志码:
A
摘要:
目的：探讨香茅草黄酮提取物对高血压大鼠降压作用及其机制。方法：用N’-硝基-L-精氨酸(L-NNA)给药4周复制高血压大鼠模型，将50只雄性高血压大鼠随机分为5组：模型组，香茅草黄酮提取物低剂量组(0.85%)、中剂量组(1.65%)、高剂量组(3.35%)，卡托普利组(1%)，每组10只；另外选取正常10只大鼠作为空白组。每日给予各组大鼠2 mL相应药物灌胃，空白组和模型组给予等量生理盐水。采用无创尾动脉测压法，每周测定大鼠收缩压(systolic pressure，SP)、舒张压(diastolic pressure，DP)1次，共4周。4周后，自腹主动脉取血，检测大鼠血清中超氧化物歧化酶(superoxide dismutase，SOD)、丙二醛(malonaldehyde,MDA)、活性氧(reactive oxygen species，ROS)、一氧化氮(nitric oxide，NO)及内皮素(endothelin-1，ET-1)的含量。结果：给药4周后，与模型组相比，香茅草黄酮提取物低、中、高剂量组，卡托普利组能显著降低大鼠收缩压、舒张压、平均动脉压(P＜0.05)，血清中SOD的含量显著高于模型组(P＜0.05)，MDA、ROS的含量均显著低于模型组(P＜0.05)，香茅草提取物中、高剂量组以及卡托普利组大鼠血清中NO水平高于模型组，ET-1水平低于模型组，差异有统计学意义(P＜0.05)。结论：香茅草提取物对L-NNA诱导的高血压大鼠血压有降压作用，其降压作用机制可能与香茅草提取物的抗氧化应激作用改善内皮功能有关。
Abstract:
Objective: To discuss the effects of flavonoid extract from Xiangmaocao (Cymbopogon citratus.) on lowering blood pressure of rat model with hypertension and its mechanism. Methods: L-NNA was given for four weeks to prepare hypertension rat models, fifty male hypertesion rats were randomized into five groups: the model group, low (0.85%), moderate (1.65%) and high (3.35%) doses groups of flavonoid extract from Xiangmaocao and the group of 1% captopril, ten rats each group, in addition, another ten normal rats were chosen as the blank group. Every day, the rats in different groups were drenched with the corresponding medicine, 2 mL, the blank group and the model group were given the same amount of normal saline. Noninvasive tail artery manometry was used to measure SP and DP each week, four weeks altogether. The contents of ET-1, NO, ROS, MDA and SOD in the serum were detected in four weeks after blood was drawn from abdominal aorta. Results: After medicating for four weeks, compared with the model group, low, moderate and high doses groups of flavonoid extract from Xiangmaocao and captopril group could notably lower SP, DP and MAP (P＜0.05), while higher than the model group in the contents of SOD (P＜0.05), lower than the model group in the contents of MDA and ROS (P＜0.05), moderate and high dose groups of flavonoid extract from Xiangmaocao and captopril group were higher than the model group in the levels of NO, lower than the model group in the levels of ET-1, and the difference was statistically significant (P＜0.05). Conclusion: Flavonoid extract from Xiangmaocao could lower blood pressure of rat model with hypertension induced by L-NNA, and its mechanism of lowering blood pressure might be related to that the extract from Xiangmaocao could fight against oxidative stress and improve endothelial function.

相似文献/References:

[1]马学芳,郜志宏.老年高血压中医证型与危险因素之间的相关性研究[J].西部中医药,2012,25(10):79.
　MA Xue-fang,GAO Zhi-hong.Relevant Study between Senile Hypertension and Risk Factors of TCM Syndrome[J].Western Journal of Traditional Chinese Medicine,2012,25(08):79.
[2]王记,指导：李应东.李应东教授以补虚活血法论治高血压经验[J].西部中医药,2013,26(04):49.
　WANG Ji,DirectorLI Yingdong.Professor LI Y ingdong's Experience of Tonifying Deficiency and Activating Blood Method for Hypertension[J].Western Journal of Traditional Chinese Medicine,2013,26(08):49.
[3]徐宏.益水生新饮对高血压早期肾损害患者血液流变学及ALB和α1-MG的影响*[J].西部中医药,2013,26(06):4.
　XU Hong.Effects of Y iShui ShengXinY in on Hemorheology, ALB and α1-MG of Hypertensive Patients with Early Renal Damage[J].Western Journal of Traditional Chinese Medicine,2013,26(08):4.
[4]魏丽丽.45例妊娠高血压患者眼底检查分析[J].西部中医药,2012,25(08):112.
　WEI Li-li.Analysis on Eyeground Examination of 45 Pregnant Patients with Hypertension[J].Western Journal of Traditional Chinese Medicine,2012,25(08):112.
[5]刘希宏.中西药物联用对老年高血压合并2型糖尿病患者肾功能的保护作用[J].西部中医药,2012,25(07):9.
　LIU Xi-hong.Protection of Integrated Traditional Chinese and Western Medicine on Renal Function of Patients with Senile Hypertension and Type 2 Diabetes Mellitus[J].Western Journal of Traditional Chinese Medicine,2012,25(08):9.
[6]张成慰.天麻钩藤饮联合氯沙坦治疗肾性高血压60例[J].西部中医药,2013,26(09):76.
　ZHANG Chengwei.TianMa GouTeng Drink and Losartan for 60 Cases of Renal Hypertension[J].Western Journal of Traditional Chinese Medicine,2013,26(08):76.
[7]刘赵丽,徐耀,张昶,等.中药腿足浴疗法治疗Ⅰ级高血压疗效观察[J].西部中医药,2013,26(10):113.
　LIU Zhaoli,XU Yao,ZHANG Chang,et al.Observation on TCM Leg-feet Balneotherapy for Hypertension Level One[J].Western Journal of Traditional Chinese Medicine,2013,26(08):113.
[8]丁劲,施兴艳.中医护理干预对肝阳上亢型高血压睡眠障碍的影响*[J].西部中医药,2013,26(10):115.
　DING Jin,SHI Xingyan.Effects of TCM Nursing Intervention on Sleep Disorder Induced by Hypertension of Liver Yang Hyperactivity Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(08):115.
[9]蒋文潇,王保和△.从气虚角度探讨眩晕与高血压病机的相关性[J].西部中医药,2014,27(03):61.
　JIANG Wenxiao,WANG Baohe.A Probe into the Relationship between the Pathogenesis of Hypertension and Vertigo from the Angle of Qi Deficiency[J].Western Journal of Traditional Chinese Medicine,2014,27(08):61.
[10]郭海莉.某医院临床高血压患者的服药依从性调查分析[J].西部中医药,2014,27(09):69.

备注/Memo

备注/Memo:
收稿日期：2019-09-13*基金项目：国家自然科学基金资助项目(81260454)。作者简介：张雪梅(1983—)，女，讲师。研究方向：病理生理学与药理学的研究。△通讯作者：孙湛(1979—)，女，博士学位，教授。研究方向：心血管病理生理学。
更新日期/Last Update: 2020-08-15